Fixed-dose rate gemcitabine alone or alternating with FOLFIRI.3 (irinotecan, leucovorin and fluorouracil) in the first-line treatment of patients with metastatic pancreatic adenocarcinoma: An AGEO randomised phase II study (FIRGEM)
Trouilloud, Isabelle, Dupont-Gossard, Anne-Claire, Malka, David, Artru, Pascal, Gauthier, Mélanie, Lecomte, Thierry, Aparicio, Thomas, Thirot-Bidault, Anne, Lobry, Céline, Asnacios, Amani, Manet-LacomVolume:
50
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2014.09.015
Date:
December, 2014
File:
PDF, 523 KB
english, 2014